Search Results
DCGI approves India's first Covid 19 vaccine for human trials
The Development of Covaxin
Bharat Biotech’s intranasal covid vaccine has been approved by government as booster dose for adults
COVID Vaccine Updates: phase 3 trials of Bharat Biotech's 'Covaxin' begins in Bengaluru
Fauci: Covaxin found to neutralise the 617 variant found in India
Bharat Biotech's Covaxin 60% Effective, How Soon Covid Vaccine Be Available In Markets?
Bharat Biotech completes trials for India's first intranasal Covid-19 vaccine | Oneindia News*News
Covaxin trial data: Bharat Biotech vaccine shows 77.8% overall efficacy, 65% against Delta variant
Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial - TV9
Indian Vaccine Candidate Covaxin Moves to Phase II
Coronavirus Vaccine | Bharat Biotech Begins Covaxin Third Phase Trials @ Guntur
Bharat Biotech’s Covaxin's Phase 3 Trial Data Looks Good: WHO Chief Scientist